Rhumbline Advisers »

Beam Therapeutics shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of Beam Therapeutics (BEAM) shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in Beam Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Beam Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Beam Therapeutics by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.6M 109k 33.04
2023-12-31 $2.8M 104k 27.22
2023-09-30 $2.5M 106k 24.05
2023-06-30 $3.0M 95k 31.93
2023-03-31 $2.7M 88k 30.62
2022-12-31 $3.4M 87k 39.11
2022-09-30 $4.0M 85k 47.64
2022-06-30 $2.9M 76k 38.70
2022-03-31 $3.1M 54k 57.30
2021-12-31 $4.1M 52k 79.69
2021-09-30 $4.5M 52k 87.00
2021-06-30 $6.3M 49k 128.71
2021-03-31 $3.5M 44k 80.04
2020-12-31 $3.8M 46k 81.64
2020-09-30 $912k 37k 24.63
2020-06-30 $410k 15k 27.99
2020-03-31 $210k 12k 17.96